139 related articles for article (PubMed ID: 19822488)
1. Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma?
Gao C; Yao SK
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):465-73. PubMed ID: 19822488
[TBL] [Abstract][Full Text] [Related]
2. Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: A population-based cohort study.
Huang TS; Lin CL; Lu MJ; Yeh CT; Liang KH; Sun CC; Shyu YC; Chien RN
J Gastroenterol Hepatol; 2017 Jul; 32(7):1355-1362. PubMed ID: 27930829
[TBL] [Abstract][Full Text] [Related]
3. Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy.
Hung CH; Lee CM; Wang JH; Hu TH; Chen CH; Lin CY; Lu SN
Int J Cancer; 2011 May; 128(10):2344-52. PubMed ID: 20669224
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan.
Chen CT; Chen JY; Wang JH; Chang KC; Tseng PL; Kee KM; Chen PF; Tsai LS; Chen SC; Lin SC; Lu SN
Kaohsiung J Med Sci; 2013 Aug; 29(8):451-9. PubMed ID: 23906236
[TBL] [Abstract][Full Text] [Related]
5. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.
Yang WS; Va P; Bray F; Gao S; Gao J; Li HL; Xiang YB
PLoS One; 2011; 6(12):e27326. PubMed ID: 22205924
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis C patients in China.
Li X; Xu H; Gao Y; Pan M; Wang L; Gao P
Medicine (Baltimore); 2017 Mar; 96(13):e6508. PubMed ID: 28353605
[TBL] [Abstract][Full Text] [Related]
7. Impact of obesity and diabetes on waitlist survival, probability of liver transplantation and post-transplant survival among chronic hepatitis C virus patients.
Aguilar M; Liu B; Holt EW; Bhuket T; Wong RJ
Liver Int; 2016 Aug; 36(8):1167-75. PubMed ID: 26858016
[TBL] [Abstract][Full Text] [Related]
8. Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review.
Dyal HK; Aguilar M; Bartos G; Holt EW; Bhuket T; Liu B; Cheung R; Wong RJ
Dig Dis Sci; 2016 Feb; 61(2):636-45. PubMed ID: 26703125
[TBL] [Abstract][Full Text] [Related]
9. Effect of type 2 diabetes mellitus on the risk for hepatocellular carcinoma in chronic liver diseases: a meta-analysis of cohort studies.
Chen J; Han Y; Xu C; Xiao T; Wang B
Eur J Cancer Prev; 2015 Mar; 24(2):89-99. PubMed ID: 24809655
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies.
Wang C; Wang X; Gong G; Ben Q; Qiu W; Chen Y; Li G; Wang L
Int J Cancer; 2012 Apr; 130(7):1639-48. PubMed ID: 21544812
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma.
Kuske L; Mensen A; Müllhaupt B; Negro F; Semela D; Moradpour D; Malé PJ; Heim MH; Malinverni R; Cerny A; Dufour JF;
Swiss Med Wkly; 2012; 142():w13651. PubMed ID: 22869395
[TBL] [Abstract][Full Text] [Related]
12. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.
Lai SW; Chen PC; Liao KF; Muo CH; Lin CC; Sung FC
Am J Gastroenterol; 2012 Jan; 107(1):46-52. PubMed ID: 22085817
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.
Hassan MM; Hwang LY; Hatten CJ; Swaim M; Li D; Abbruzzese JL; Beasley P; Patt YZ
Hepatology; 2002 Nov; 36(5):1206-13. PubMed ID: 12395331
[TBL] [Abstract][Full Text] [Related]
14. Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection.
Toyoda H; Kumada T; Tada T; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Ito T
J Gastroenterol Hepatol; 2015 Jul; 30(7):1183-9. PubMed ID: 25678094
[TBL] [Abstract][Full Text] [Related]
15. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management.
Singh MK; Das BK; Choudhary S; Gupta D; Patil UK
Biomed Pharmacother; 2018 Oct; 106():991-1002. PubMed ID: 30119271
[TBL] [Abstract][Full Text] [Related]
16. Prevention of hepatocellular carcinoma: progress and challenges.
Shire AM; Roberts LR
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):49-64. PubMed ID: 22419004
[TBL] [Abstract][Full Text] [Related]
17. Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies.
Tung HD; Wang JH; Tseng PL; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen YD; Lu SN
Am J Gastroenterol; 2010 Mar; 105(3):624-31. PubMed ID: 20051944
[TBL] [Abstract][Full Text] [Related]
18. Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus.
Konishi I; Hiasa Y; Shigematsu S; Hirooka M; Furukawa S; Abe M; Matsuura B; Michitaka K; Horiike N; Onji M
Liver Int; 2009 Sep; 29(8):1194-201. PubMed ID: 19422477
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
Veldt BJ; Chen W; Heathcote EJ; Wedemeyer H; Reichen J; Hofmann WP; de Knegt RJ; Zeuzem S; Manns MP; Hansen BE; Schalm SW; Janssen HL
Hepatology; 2008 Jun; 47(6):1856-62. PubMed ID: 18506898
[TBL] [Abstract][Full Text] [Related]
20. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States.
Hassan MM; Kaseb A; Li D; Patt YZ; Vauthey JN; Thomas MB; Curley SA; Spitz MR; Sherman SI; Abdalla EK; Davila M; Lozano RD; Hassan DM; Chan W; Brown TD; Abbruzzese JL
Hepatology; 2009 May; 49(5):1563-70. PubMed ID: 19399911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
